EKATERINA KHAYTSIS: Open Payments
NPI 1417422395 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$996 in 36 payments from 13 companies in 2025. Trend: 2023 $391 · 2024 $1,584 · 2025 $996
Food & beverage: $996
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $314 |
| ABBVIE INC. | 8 | $210 |
| Alkermes, Inc. | 5 | $138 |
| Lundbeck LLC | 2 | $67 |
| Vanda Pharmaceuticals Inc. | 1 | $39 |
| Janssen Pharmaceuticals, Inc | 1 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $35 |
| Corium, LLC | 1 | $29 |
| Almatica Pharma LLC | 1 | $29 |
| Biogen, Inc. | 1 | $28 |
Products named: REXULTI, VRAYLAR, LYBALVI, ABILIFY MAINTENA, FANAPT, SPRAVATO, INGREZZA, ABILIFY ASIMTUFII.
Industry payments across NY — which companies pay providers there.
